Rakesh Kumar Gupta1, Ulrich Katscher2, Rupsa Bhattacharjee3, Mamta Gupta1, and Indrajit Saha 3
1Department of Radiology, Fortis Memorial Research Institute, Gurugram, India, 2Philips GmbH / Innovative Technologies / Research Laboratories, Hamburg, Germany, 3Philips Health Systems, Philips India Limited, Gurugram, India
Synopsis
Breast tissue conductivity map
based on EPT MRI is one of the non-contrast methods that can differentiate
malignant from benign breast lesions; however, the need for DCE based tumor
“mask” to generate conductivity maps from the phase of VISTA images in breast
challenges EPT’s role as a non-contrast method. This study demonstrates an
alternative to reconstruct breast tissue conductivity maps using T2-w mDixon
TSE sequence that is comparable with DCE/VISTA method, and demonstrates similarities
in detecting cancerous tissues. EPT maps of breast using T2-w mDixon TSE method
has the potential to help in developing non-contrast MR breast cancer screening
protocol.
Introduction
Recent reports of Gadolinium deposition in
tissue due to contrast injections during conventional contrast enhanced (CE) MR
scans has generated increased interest among researchers to develop
non-contrast alternative methods for the precision diagnosis of tumors. One
such emerging non-contrast quantitative method that takes the advantage of the
difference in tissue conductivities in MR is Electric Properties Tomography
(EPT) methodology. In 1991, Haacke et. al. first demonstrated the possibility
of derivation of electrical properties of tissues from measurable MR field which
led to the estimation of tissue conductivity non-invasively using phase maps. Commonly
in breast, EPT uses phase maps of a 3D-TSE (VISTA) sequence to generate conductivity
maps. Clinical studies
have already shown the ability of MR conductivity mapping to distinguish benign
and malignant breast tumors [1-2]. However, the EPT method is challenged by the
need for an ideal method of tumor delineation for conductivity reconstruction
which commonly is performed by using a “mask” generated from the DCE perfusion
images for breast tumors; and thus, the purpose of developing an EPT based
non-contrast method for identifying malignant breast tissues fails to serve its
purpose. This pilot study explores an alternative method of using the T2-weighted
multi-slice mDixon TSE based tumor delineation for EPT reconstruction and
compares the results with EPT reconstruction using prior knowledge of tumor
using the DCE images. Methods
This
institutional ethical committee approved study explored different EPT
reconstruction methods of MR images from 11 patients with proven histopathology
and BIRAD grades (2 patients with BIRAD-2, 6 patients with BIRAD-4, 2 patients
with BIRAD-5 and 1 patient with BIRAD-6). Using a 7-channel breast coil at 3T
MRI (Ingenia, Philips Healthcare, Best, The Netherlands) three sequences were
used in this study – 1. 3D-TSE (VISTA) with phase images 2. T2 mDixon-TSE multi-slice
with magnitude and phase images and 3. DCE perfusion (dynamic acquisition using
3D-TFE mDixon). Images of these three sequences were spatially
registered. Binary tumor masks were derived from DCE mages. Based on the phase
of the VISTA images, conductivity of each patient was reconstructed using DCE
masks. Additionally, conductivity was reconstructed using the phase of the
T2-weighted mDixon TSE images. In this case, no mask was used since all
T2-weighted Dixon images showed sufficient tumor contrast for accurate
conductivity reconstruction. After applying numerical Laplacian operator to the phase to obtain the
raw conductivity, a denoising median filter was applied. The kernels for both,
Laplacian and denoising filter, were shaped locally according to tissue
boundaries. Conductivities
were averaged first over the voxels of the individual lesions and then over
each BIRADS category. Results
The
mean lesion conductivities averaged over each BIRADS category are shown in Fig.
1. Lesions of BIRAD-2 (i.e., benign) clearly show lower conductivity values
(reconstructed from VISTA phase using mask from DCE and represented as
VISTA/DCE) with respect to the lesions of higher BIRAD categories (i.e.,
suspicious and malignant). The statistical significance of this finding is low,
since only two reconstructed lesions had BIRAD-2, but agrees with findings of
other studies with a higher number of patients [1,2]. On the other hand, conductivities
reconstructed from T2-w mDixon TSE images confirm the finding from
VISTA/DCE-based conductivity reconstructions of breast lesions. Discussion
Development
of a robust non-contrast method for breast tumor detection is an unmet need
especially to make MRI based routine breast cancer screening more effective.
This study explores EPT as an option to address the requirement. To make EPT a truly
useful non-CE method, this study adopts a new strategy to generate breast
tissue conductivity maps using phase and magnitude images of T2 mDixon TSE with
superior fat-suppression over conventional fat-sat techniques to bypass the commonly
used tumor mask generated from breast DCE scan. The results of breast tissue
conductivity of T2 mDixon TSE images are comparable with VISTA/DCE method. In
addition, within a given BIRADS category, mean conductivities from T2-weighted mDixon
TSE images show a trend towards a lower variability than mean conductivities
from VISTA/DCE indicating possibility of achieving higher specificity using EPT
for breast cancer detection. In near future, a similar study with larger
patient population will be able to determine the sensitivity and specificity of
the EPT maps generated from T2 mDixon TSE for detecting breast tumors to
enhance the efficacy of MR based non-CE breast cancer screening. Conclusion
Breast
tissue conductivity maps generated from EPT reconstruction has the potential to
detect and separate benign from malignant tissues. This pilot study
demonstrates that generation of conductivity maps from T2 mDixon TSE scans in a
routine breast MR protocol can replace the need of DCE scans to generate breast
EPT maps. This work opens up the possibility to develop EPT based non-CE breast
screening protocol in future. Acknowledgements
No acknowledgement found.References
[1] Shin JW et
al.; J Magn Reson Imag. 2015;42: 371;
[2] Mori N et al.,. Eur Radiol. 2019;29: 1778